SG11201913161WA - Novel compounds activating the nrf2 pathway - Google Patents

Novel compounds activating the nrf2 pathway

Info

Publication number
SG11201913161WA
SG11201913161WA SG11201913161WA SG11201913161WA SG11201913161WA SG 11201913161W A SG11201913161W A SG 11201913161WA SG 11201913161W A SG11201913161W A SG 11201913161WA SG 11201913161W A SG11201913161W A SG 11201913161WA SG 11201913161W A SG11201913161W A SG 11201913161WA
Authority
SG
Singapore
Prior art keywords
novel compounds
nrf2 pathway
compounds activating
activating
nrf2
Prior art date
Application number
SG11201913161WA
Other languages
English (en)
Inventor
Duran Carlos Puig
Palomera Fernando Albericio
Benitez Miriam Gongora
Bas Marta Paradis
Casals Laia Miret
Tomillero Ivan Ramos
Stephen Fiacco
Andrew Davis
Stefan Geschwindner
Cubero Omar Brun
Paniagua Carlos Heras
Canela Nuria Trallero
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of SG11201913161WA publication Critical patent/SG11201913161WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG11201913161WA 2017-08-08 2018-08-08 Novel compounds activating the nrf2 pathway SG11201913161WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382558 2017-08-08
PCT/EP2018/071536 WO2019030298A1 (en) 2017-08-08 2018-08-08 NEW COMPOUNDS THAT ACTIVATE THE NRF2 PATH

Publications (1)

Publication Number Publication Date
SG11201913161WA true SG11201913161WA (en) 2020-01-30

Family

ID=59677167

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201913161WA SG11201913161WA (en) 2017-08-08 2018-08-08 Novel compounds activating the nrf2 pathway

Country Status (24)

Country Link
US (1) US20200255478A1 (ar)
EP (1) EP3665182A1 (ar)
JP (1) JP2020530022A (ar)
KR (1) KR20200035269A (ar)
CN (1) CN110997695A (ar)
AR (1) AR113100A1 (ar)
AU (1) AU2018314833B2 (ar)
BR (1) BR112019026306A2 (ar)
CA (1) CA3066698A1 (ar)
CL (1) CL2020000305A1 (ar)
CO (1) CO2020000617A2 (ar)
CR (1) CR20200056A (ar)
DO (1) DOP2020000017A (ar)
EA (1) EA202090432A1 (ar)
EC (1) ECSP20008530A (ar)
IL (1) IL272467A (ar)
JO (1) JOP20200025A1 (ar)
MA (1) MA49828A (ar)
MX (1) MX2020001481A (ar)
PE (1) PE20211460A1 (ar)
PH (1) PH12019502852A1 (ar)
SG (1) SG11201913161WA (ar)
TW (1) TW201919682A (ar)
WO (1) WO2019030298A1 (ar)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202340226A (zh) * 2021-12-17 2023-10-16 德商3B製藥有限公司 碳酸酐酶ix配位體

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7920688V0 (it) 1979-02-05 1979-02-05 Chiesi Paolo Parma Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore.
CY1492A (en) 1981-07-08 1990-02-16 Draco Ab Powder inhalator
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FI69963C (fi) 1984-10-04 1986-09-12 Orion Yhtymae Oy Doseringsanordning
DE3927170A1 (de) 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
IT1237118B (it) 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
WO1992003175A1 (en) 1990-08-11 1992-03-05 Fisons Plc Inhalation device
DE4027391A1 (de) 1990-08-30 1992-03-12 Boehringer Ingelheim Kg Treibgasfreies inhalationsgeraet
ATE164525T1 (de) 1990-09-26 1998-04-15 Pharmachemie Bv Inhalator mit einem reservoir für mehrere dosierte inhalationsmittel, mit transportvorrichtung und mit wirbelkammer
GB9026025D0 (en) 1990-11-29 1991-01-16 Boehringer Ingelheim Kg Inhalation device
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
DE4239402A1 (de) 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
WO1994014492A2 (en) 1992-12-18 1994-07-07 Schering Corporation Inhaler for powdered medications
EP0820323B1 (en) 1995-04-14 2003-09-24 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
SI9620081B (en) 1995-06-21 2001-06-30 Asta Medica Ag Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
ES2500921T3 (es) 2003-04-29 2014-10-01 Sarepta Therapeutics, Inc. Composiciones para potenciar el transporte y la eficacia antisentido de análogos de ácidos nucleicos en células
MX2007000592A (es) 2004-07-16 2008-03-04 Almirall Lab Inhalador para la administracion de farmaceuticos en polvo, y un sistema de cartuchos de polvo para uso con este inhalador.
MY150075A (en) 2007-02-28 2013-11-29 Leo Pharma As Novel phosphodiesterase inhibitors
US8575305B2 (en) 2008-06-04 2013-11-05 Medical Research Council Cell penetrating peptides
JP2012051826A (ja) * 2010-08-31 2012-03-15 Toray Ind Inc 環状ペプチド及びその修飾ペプチド並びにKelch様ECH結合タンパク質1の結合阻害物質のスクリーニング方法
IL273838B (en) 2011-05-05 2022-09-01 Sarepta Therapeutics Inc Peptide and oligonucleotide conjugates, preparations containing them and their uses
CN103998458B (zh) 2011-08-30 2018-10-09 医学研究理事会 具有中央疏水域的细胞穿透肽
JP2015067579A (ja) * 2013-09-30 2015-04-13 国立大学法人東北大学 細胞透過性ペプチド及び当該ペプチドを含む医薬組成物。

Also Published As

Publication number Publication date
CA3066698A1 (en) 2019-02-14
CO2020000617A2 (es) 2020-05-05
KR20200035269A (ko) 2020-04-02
JOP20200025A1 (ar) 2020-02-04
PH12019502852A1 (en) 2020-09-28
CN110997695A (zh) 2020-04-10
ECSP20008530A (es) 2020-05-29
TW201919682A (zh) 2019-06-01
PE20211460A1 (es) 2021-08-05
BR112019026306A2 (pt) 2020-07-14
IL272467A (en) 2020-03-31
MX2020001481A (es) 2020-03-20
CL2020000305A1 (es) 2020-06-26
DOP2020000017A (es) 2020-02-28
AR113100A1 (es) 2020-01-29
WO2019030298A1 (en) 2019-02-14
EA202090432A1 (ru) 2020-06-08
CR20200056A (es) 2020-03-16
AU2018314833B2 (en) 2020-03-19
EP3665182A1 (en) 2020-06-17
AU2018314833A1 (en) 2020-01-02
MA49828A (fr) 2020-06-17
JP2020530022A (ja) 2020-10-15
US20200255478A1 (en) 2020-08-13

Similar Documents

Publication Publication Date Title
IL272467A (en) Novel compounds that activate the NRF2 pathway
GB201702947D0 (en) Novel compounds
IL272562A (en) new compounds
GB201720187D0 (en) Novel Compounds
PT3668853T (pt) Novos compostos
GB201719543D0 (en) The enclosed degravitator
GB201720386D0 (en) The twizzler
GB201717702D0 (en) The Privvy
GB201721727D0 (en) Novel compounds
GB201721735D0 (en) Novel Compounds
GB201721732D0 (en) Novel Compounds
GB201721731D0 (en) Novel compounds
GB201721736D0 (en) Novel Compounds
GB201721726D0 (en) Novel compounds
GB201721729D0 (en) Novel compounds
GB201719720D0 (en) Novel compounds
GB201718564D0 (en) Novel compounds
GB201718565D0 (en) Novel compounds
GB201718561D0 (en) Novel compounds
GB201718563D0 (en) Novel compounds
GB201716131D0 (en) Novel compounds
GB201714699D0 (en) Novel compounds
GB201713083D0 (en) Novel compounds
GB201713082D0 (en) Novel compounds
GB201713079D0 (en) Novel Compounds